ChemicalBook
English   Japanese   Germany   Korea

(1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol

, 18269-16-4, 结构式
CAS号:
18269-16-4
英文名:
(1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol
英文别名:
Voaphylline hydroxyindolenine;Voaphylline hydroxyindolenine【neutral】;(1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol;2H-3,13-Methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol, 13-ethyl-4,5,11,12,13,13a-hexahydro-, (1aR,5aR,13S,13aS)-
中文名:
中文别名:
CBNumber:
CB92199178
分子式:
C19H24N2O2
分子量:
312.41
MOL File:
18269-16-4.mol

(1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol化学性质

沸点:
478.8±45.0 °C(Predicted)
密度:
1.38±0.1 g/cm3(Predicted)
酸度系数(pKa):
12.38±0.40(Predicted)
安全信息

(1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol性质、用途与生产工艺

(1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol 上下游产品信息

上游原料

下游产品

(1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol 生产厂家

全球有 0家供应商   (1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol国内生产厂家
 

18269-16-4, (1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol 相关搜索:

  • 18269-16-4
  • 2H-3,13-Methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol, 13-ethyl-4,5,11,12,13,13a-hexahydro-, (1aR,5aR,13S,13aS)-
  • Voaphylline hydroxyindolenine【neutral】
  • Voaphylline hydroxyindolenine
  • (1aR,5aR,13S,13aS)-13-Ethyl-4,5,11,12,13,13a-hexahydro-2H-3,13-methanooxireno[9,10]azacycloundecino[5,4-b]indol-5a(1aH)-ol
Copyright 2016 © ChemicalBook. All rights reserved